Troutman Pepper Locke Named Finalist for LMG Life Sciences Mid-Market Transactions Firm of the Year

NEW YORK – Troutman Pepper Locke has been shortlisted for Mid-Market Transactions Firm of the Year by LMG Life Sciences, reflecting the firm’s depth of experience advising pharmaceutical, biotech, medical device, diagnostics, and other life sciences companies on complex mid-market transactions. The winner will be announced at the 14^th annual LMG Life Sciences Americas Awards ceremony on September 10, 2026, in New York.

The LMG Life Sciences Americas Awards bring together the legal community across North and South America to celebrate excellence in life sciences law, recognizing the firms, lawyers, and in-house teams who have demonstrated leadership across key practice areas, including transactions, litigation, and regulatory work.

Troutman Pepper Locke’s leading Health Care and Life Sciences Practice encompasses the entire spectrum of health care and life sciences companies. The team collaborates across disciplines to solve complex legal challenges confronting clients, offering a full suite of corporate, intellectual property, regulatory, and litigation services. Few law firms have a comparable health care and life sciences practice, and Troutman Pepper Locke draws on its deep industry knowledge to provide the precise, holistic advice and guidance clients need throughout their business cycles.

Troutman Pepper Locke

Troutman Pepper Locke helps clients solve complex legal challenges and achieve their business goals in an ever-changing global economy. With more than 1,600 attorneys in 30+ offices, the firm serves clients in all major industry sectors, with particular depth in energy, financial services, health care and life sciences, insurance and reinsurance, private equity, and real estate. Learn more at troutman.com.

• Health Care + Life Sciences
• Life Sciences Transactions